Pfizer opens research and development centre in Beijing

US pharmaceutical giant Pfizer's new research and development (R&D) centre officially opened at BioPark in the Beijing Economic-Technological Development Area (BDA).As the company's third R&D centre in China, the new facility aims to enhance its existing drug development network in the country, integrat...